BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

443 related articles for article (PubMed ID: 18082543)

  • 1. The effectiveness of extended lymph node dissection for gastric cancer performed in Costa Rica under the supervision of a Japanese surgeon: a comparison with surgical results in Japan.
    Sasagawa T; Solano H; Vega W; Mena F
    Am J Surg; 2008 Jan; 195(1):53-60. PubMed ID: 18082543
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Surgical outcome of 801 patients with localized gastric cancer treated with d2 lymphadenectomy].
    Ruiz E; Sanchez J; Celis J; Payet E; Berrospi F; Chavez I; Young F
    Rev Gastroenterol Peru; 2009; 29(2):124-31. PubMed ID: 19609327
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Does extended lymphadenectomy influence prognosis of gastric carcinoma after curative resection?
    Ramacciato G; Aurello P; D'Angelo F; Cicchini C; Sternberg CN
    Hepatogastroenterology; 2000; 47(35):1470-4. PubMed ID: 11100379
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Surgical outcome of 483 patients with early gastric cancer: prognosis, postoperative morbidity and mortality, and gastric remnant cancer.
    Onodera H; Tokunaga A; Yoshiyuki T; Kiyama T; Kato S; Matsukura N; Masuda G; Tajiri T
    Hepatogastroenterology; 2004; 51(55):82-5. PubMed ID: 15011835
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [D3 versus D2 dissection in stomach carcinoma. A case-control study of postoperative morbidity, survival and early oncologic outcome].
    Bittorf BR; Günther F; Merkel S; Horbach T; Hohenberger W; Günther K
    Chirurg; 2002 Apr; 73(4):336-47. PubMed ID: 12063918
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prognostic benefit of extended radical lymphadenectomy for patients with gastric cancer.
    Ikeguchi M; Oka S; Gomyo Y; Tsujitani S; Maeta M; Kaibara N
    Anticancer Res; 2000; 20(2B):1285-9. PubMed ID: 10810436
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Resection for gastric cancer in the community.
    van de Velde CJ
    Semin Oncol; 2005 Dec; 32(6 Suppl 9):S90-3. PubMed ID: 16399441
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Rational evaluation of different lymph node dissection].
    Chen JQ; Wang SB; Qi CL
    Zhonghua Yi Xue Za Zhi; 1995 Feb; 75(2):110-3, 128. PubMed ID: 7767766
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Extended lymph node dissection for gastric cancer: who may benefit? Final results of the randomized Dutch gastric cancer group trial.
    Hartgrink HH; van de Velde CJ; Putter H; Bonenkamp JJ; Klein Kranenbarg E; Songun I; Welvaart K; van Krieken JH; Meijer S; Plukker JT; van Elk PJ; Obertop H; Gouma DJ; van Lanschot JJ; Taat CW; de Graaf PW; von Meyenfeldt MF; Tilanus H; Sasako M
    J Clin Oncol; 2004 Jun; 22(11):2069-77. PubMed ID: 15082726
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Is extended lymph node dissection necessary for gastric cancer in elderly patients?
    Eguchi T; Takahashi Y; Ikarashi M; Kasahara M; Fujii M
    Eur J Surg; 2000 Dec; 166(12):949-53. PubMed ID: 11152256
    [TBL] [Abstract][Full Text] [Related]  

  • 11. An evaluation of the effectiveness of extended lymph node dissection in patients with gastric cancer: a retrospective study of 1403 cases at a single institution.
    Kasakura Y; Mochizuki F; Wakabayashi K; Kochi M; Fujii M; Takayama T
    J Surg Res; 2002 Apr; 103(2):252-9. PubMed ID: 11922742
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of laparoscopy-assisted by conventional open distal gastrectomy and extraperigastric lymph node dissection in early gastric cancer.
    Kim MC; Kim KH; Kim HH; Jung GJ
    J Surg Oncol; 2005 Jul; 91(1):90-4. PubMed ID: 15999352
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Limited effectiveness of extended lymph-node dissection for node-negative patients with proximal gastric cancer.
    Kikuchi S; Katada N; Sakuramoto S; Kobayashi N; Shimao H; Sakakibara Y; Sato K; Kakita A
    Anticancer Res; 2001; 21(2B):1359-62. PubMed ID: 11396213
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Morbidity and mortality after D1 and D2 gastrectomy for cancer: interim analysis of the Italian Gastric Cancer Study Group (IGCSG) randomised surgical trial.
    Degiuli M; Sasako M; Calgaro M; Garino M; Rebecchi F; Mineccia M; Scaglione D; Andreone D; Ponti A; Calvo F;
    Eur J Surg Oncol; 2004 Apr; 30(3):303-8. PubMed ID: 15028313
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of surgical results of D2 versus D3 gastrectomy (para-aortic lymph node dissection) for advanced gastric carcinoma: a multi-institutional study.
    Kunisaki C; Akiyama H; Nomura M; Matsuda G; Otsuka Y; Ono H; Nagahori Y; Hosoi H; Takahashi M; Kito F; Shimada H
    Ann Surg Oncol; 2006 May; 13(5):659-67. PubMed ID: 16538414
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [The role of superextended lymphadenectomy (D4) in gastric cancer].
    Pugliese R; Maggioni D; Sansonna F; Scandroglio I; Di Lernia S; Boniardi M; Bramerio MA
    Minerva Chir; 2004 Aug; 59(4):325-35. PubMed ID: 15278027
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Videolaparoscopic total and subtotal gastrectomy with extended lymph node dissection for gastric cancer.
    Huscher CG; Mingoli A; Sgarzini G; Sansonetti A; Lirici MM; Napolitano C; Piro F
    Am J Surg; 2004 Dec; 188(6):728-35. PubMed ID: 15619491
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prophylactic lymph node dissection for early gastric cancer invading submucosa.
    Ikeda Y; Saku M; Kawanaka H; Nonaka M; Yoshida K; Maehara Y; Sugimachi K
    Hepatogastroenterology; 2004; 51(57):887-90. PubMed ID: 15143940
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Extended lymph-node dissection for gastric cancer.
    Bonenkamp JJ; Hermans J; Sasako M; van de Velde CJ; Welvaart K; Songun I; Meyer S; Plukker JT; Van Elk P; Obertop H; Gouma DJ; van Lanschot JJ; Taat CW; de Graaf PW; von Meyenfeldt MF; Tilanus H;
    N Engl J Med; 1999 Mar; 340(12):908-14. PubMed ID: 10089184
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Postoperative morbidity and mortality after gastrectomy for gastric carcinoma.
    Ikeguchi M; Oka S; Gomyo Y; Tsujitani S; Maeta M; Kaibara N
    Hepatogastroenterology; 2001; 48(41):1517-20. PubMed ID: 11677999
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.